Table 2.
Tumor grades | ||||||
---|---|---|---|---|---|---|
I/I–II | II/II–III | III/III–IV | IV | R/P value | ||
cGAS | −/+ | 6 (66.7%) | 3 (18.8%) | 5 (41.7%) | 0 (0%) | |
++ | 3 (33.3%) | 7 (43.8%) | 5 (41.7%) | 1 (25%) | ||
+++ | 0 (0%) | 6 (37.4%) | 2 (16.6%) | 3 (75%) | R = 0.3211 | |
Total | 9 (100%) | 16 (100%) | 12 (100%) | 4 (100%) | P = 0.0406 | |
DNA‐PKcs | −/+ | 5 (55.6%) | 3 (18.8%) | 6 (50%) | 0 (0%) | |
++ | 4 (44.4%) | 10 (62.5%) | 1 (8.3%) | 0 (0%) | ||
+++ | 0 (0%) | 3 (18.8%) | 5 (41.7%) | 4 (100%) | R = 0.4335 | |
Total | 9 (100%) | 16 (100%) | 12 (100%) | 4 (100%) | P = 0.0046 |
Summary of the expression patterns of DNA‐PKcs and cGAS in human glioma samples. The correlation between tumor grades and DNA‐PKcs or cGAS protein levels was analyzed using Pearson correlation test. A P‐value of < 0.05 was set as the criterion for statistical significance.